Canopy Growth Corp.’s (TSX:WEED) Revenue Soars in First Quarter Since Pot Legalization

Canopy Growth Corp. (TSX:WEED)(NYSE:CGC) saw its revenues soar in the first quarter of legal recreational marijuana.

| More on:
A stock price graph showing growth over time

Image source: Getty Images.

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn more

Canopy Growth (TSX:WEED)(NYSE:CGC) released its third-quarter results for fiscal 2019 on Valentine’s Day, which saw a strong surge in revenue following the legalization of recreational marijuana four months ago.

Big revenue surge, shift to profitability

Canopy reported solid revenues of $83 million for the third quarter ended December 31, 2018, up 256% from the same quarter a year earlier. Analysts were expecting a lower revenue of $81 million.

What contributed to this revenue surge is the legalization of recreational marijuana on October 17. More than 70% of the 10,102 kilograms of cannabis sold in the quarter were destined for recreational marijuana users.

Canopy incurred a net operating loss of $157 million, as the company spent to increase operations, capacity and hiring in order to get ready for the new cannabis regime. After a surprise net loss of $330 million in the last quarter, the company is shifting to profitability, posting a net income of $74.8 million or $0.22 a share.

With more than $5 billion in cash, Canopy is well equipped to continue spending so it can get a larger market share in the rapidly growing cannabis market.

Sales are expected to reach $805 million in 2020, while earnings are expected to amount to $0.07 per share in 2020.

Canopy is well positioned to become a global titan

A report by CIBC World Markets says that only a few marijuana companies will survive, and that Canopy has the highest chances of becoming a global titan.

Why so? According to CIBC’s report, Canopy has billions in the bank, has a best-in-class management team, the potential to make breakthroughs with new medical products, and global aspirations.

As the largest and most well-known cannabis company in the world, Canopy also has a big advantage on global competitors. The cannabis producer has a big production capacity of 4.3 million square feet.

Canopy has been acquiring other companies at a fast pace and expanding internationally, with operations in 15 countries.

The company started by growing medical marijuana and branched into recreational cannabis.

However, the company still retains a strong focus on medical cannabis, where management see global opportunity and the potential to develop cannabis products to help with sleep, pain treatment, mood therapy, and even anxiety treatments for pets.

Constellation Brands, a U.S. beer, wine and spirits company, invested $5.2 billion into Canopy to develop cannabis drinks — an investment should put Canopy in good position to benefit from moves by nine states, including Constellation’s home base of New York, toward legalization.

Canopy plans to launch cannabis drinks this year, which the company promises will be healthier alternatives to alcohol, with no hangover and containing low calories.

Earlier in January, Canopy announced its entry into the fledging U.S. hemp industry with an investment of $150 million in production facilities in the state of New York — a position that has now been increased to $500 million for hemp operations across the United States.

Is it time to buy some share of Canopy?

While Canopy’s stock is up almost 70% year-to-date, trading around $62, it’s still far from the all-time high of $73.75 it reached on October 15. While I think Canopy is one of the best cannabis companies, I don’t think it’s time to buy shares. The valuation is very hefty, with a forward P/E over 900.

Canopy has a huge market cap over $20 billion, but a lot of that money is speculation capital, which could drop quickly following negative news.

Recreational cannabis has been legal in Canada for only four months, and there have been problems to supply enough cannabis to meet demand. Once these supply issues are resolved, you can expect to see significant top-line growth, but there will surely be a lot of volatility in pot stocks prices in the meantime.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Stephanie Bedard-Chateauneuf owns shares of Canopy Growth.

More on Investing

money cash dividends
Dividend Stocks

Market Correction: 2 Oversold TSX Dividend Stocks to Buy for Total Returns

These top value stocks pay attractive dividends and look cheap to buy for a TFSA or RRSP focused on total…

Read more »

Volatile market, stock volatility
Investing

Safe TSX Stocks to Buy in a Volatile Market

Are you looking for safe TSX stocks to buy in a volatile market? Here are three top picks!

Read more »

Bank sign on traditional europe building facade
Bank Stocks

Should You Buy Canadian Bank Stocks After the Recent Correction?

Dividends and fairly valued Canadian bank stocks look attractive. But the macro picture could be a spoiler!

Read more »

Knowledge concept with quote written on wooden blocks
Investing

The 2 Best Stocks to Own in a Recession

Recessions cut demand, but essential services like Metro (TSX:MRU) could fare better.

Read more »

Group of industrial workers in a refinery - oil processing equipment and machinery
Energy Stocks

2 Energy Stocks (With Dividends) to Buy Amid the Market Correction

These dividend-yielding energy stocks look attractive to buy for the long term after their recent dip.

Read more »

Dividend Stocks

2 Undervalued TSX Dividend Stocks to Buy in July

These unloved TSX dividend stocks could deliver attractive returns in the back half of 2022.

Read more »

sad concerned deep in thought
Dividend Stocks

$20 Billion Telco Merger: More Concessions and Conditions Ahead?

The mediation process in the proposed telco merger could lead to more concessions and conditions before the competition watchdog grants…

Read more »

Question marks in a pile
Cryptocurrency

Is the Crypto Market Finally Recovering?

The decision to hold, buy, or sell crypto based on the current rally might be too immature. It would be…

Read more »